Prader-Willi syndrome (PWS) is a metabolic disorder caused by genetic defects; among its features are short stature, mental retardation, poor muscle tone, and hyperphagia, which leads to childhood ...
GlobalData on MSN15h
Aardvark prices $94.2m IPO to fund development of Prader-Willi syndrome drugAardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback